fda bpc 157 category 2 bulk drug substance compounding list FDA's Overreach on Compounded Peptides Exciting news for peptides coming

Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Survey: Half of Peptide Users Aren't Aware of FDA Approval Status

SKU: 95244326769 · From composequickly.com